Evidence map›Paper›PMID 41112191›Full record

ReviewTobacco prevention & cessation2025

The effectiveness of nicotine replacement therapy on oral smokeless tobacco cessation and reduction rate: A systematic review.

Ibtisam Moafa

Abstract readReview
In one paragraph

Review in Tobacco prevention & cessation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ibtisam MoafaDepartment of Preventive Dental Sciences, Jazan University, Jazan, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOral smokeless tobacco (OST) is a major preventable risk factor for oral cancer. Nicotine replacement therapy (NRT), a commonly used pharmacological treatment in tobacco cessation interventions that help in reducing the withdrawal symptoms that individuals might experience in their attempt to quit. This systematic review aimed to assess NRT's effectiveness on OST cessation and reduction rates, addressing gaps in prior studies by incorporating recent research across diverse populations, including developing and developed countries.

methodsA systematic search was conducted across PubMed, Cochrane, Embase, and Web of Science. The inclusion criteria were: English articles (2004 to June 2024), OST users of both genders, NRT intervention, control group (generic, placebo, or no intervention), and a 7-day point prevalence of OST abstinence and reduction at week 12. Studies were excluded if they lacked relevant outcomes, were non-English, or published before 2004. Data abstraction forms were used to extract study characteristics and results. The Practical Meta-Analysis Effect Size Calculator determined the effect sizes and directions. The risk of bias was assessed using Cochrane Collaboration's tool.

resultsEleven studies were included with 40-1067 sample size. Seven were effective on OST abstinence, with effect sizes ranging from d=0.10 to d=0.54 and odds ratios from OR=1.67 to OR=4.10. One study demonstrated OST reduction (d=0.16 for dips/day and d=0.17 for cans/week). Nicotine dependence, NRT dosage, self-efficacy and social support were identified as key factors influencing the NRT's effectiveness in the included studies.

conclusionsNRT can aid in OST cessation. Combination of NRT with other interventions such as coach calls and web-based interactive setting can enhance the OST abstinence rate. The evidence, though promising, is limited by study variability, and inconsistent outcome reporting. Future studies should explore self-efficacy, social support, and NRT dosage with larger sample sizes for better assessment.

Indexed as

cessationcommunity healthnicotine replacement therapyoral cancersmokeless-tobacco

Identifiers

PMID41112191
PMCPMC12529857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.